Loading stock data…
$22.70+0.05 (+0.20%)
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally.
Envista Holdings Corporation in the Healthcare sector is trading at $22.70 with a market capitalization of $4.3B. Wall Street consensus targets $29.54 (13 analysts), implying a +30.2% move over the next 12 months. The stock is currently 25% below its 52-week high of $30.42, remaining 11.7% below its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality, Altman Z in the distress zone. Risk note: RSI 26 is oversold, raising the odds of a near-term bounce. The Whystock Score of 60/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $730.50M↑ | $705.50M↓ | $750.60M↑ | $669.90M↓ | $682.10M |
| Gross Profit | $407.00M↑ | $390.10M↓ | $410.60M↑ | $370.20M | $369.90M |
| Operating Income | $80.30M↑ | $66.20M↓ | $93.00M↑ | $57.50M↑ | $46.30M |
| Net Income | $53.70M↑ | $38.70M↑ | $32.90M↑ | -$30.30M↓ | $26.40M |
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Eq...